CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Other events
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 52,302 shares at $4.78 ($250,004)
- 4 Open-market buy President and CEO bought 73,222 shares at $4.78 ($350,001)
- 4 Open-market buy Director bought 20,000 shares at $4.78 ($95,600)
- 4 Open-market buy VP, CFO bought 5,000 shares at $4.78 ($23,900)
- 4 Open-market buy Director bought 5,230 shares at $4.78 ($24,999)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
- S-3 Offering Registration Statement
Page 30 of 50 · 1,000 filings